Catherine Spier
Impact in
- Pathology and Forensic Medicine top 0.5%
- Lymphoma Diagnosis and Treatment
- Oncology top 1%
- Drug Transport and Resistance Mechanisms
- Viral-associated cancers and disorders
- CAR-T cell therapy research
Papers in
-
- Lymphoma Diagnosis and Treatment 44
- Oncology 25
- Drug Transport and Resistance Mechanisms 6
- Viral-associated cancers and disorders 6
- Co-authors
- Thomas M. Grogan (27 shared papers)Thomas P. Miller (28 shared papers)Richard I. Fisher (18 shared papers)Michael LeBlanc (19 shared papers)William S. Dalton (3 shared papers)TP Miller (3 shared papers)Ellen Chase (2 shared papers)David J. Adelstein (1 shared paper)
- Journals
- Blood (14 papers)Journal of Clinical Oncology (12 papers)Cancer (5 papers)Molecular Cancer Therapeutics (2 papers)Cancer Immunology Immunotherapy (2 papers)
- Partner nations
- United StatesNetherlandsMalaysia
In The Last Decade
Catherine Spier
70 papers receiving 3.5k citations
Catherine Spier's Hit Papers
Peers
Comparison fields: 5 of 91
- Pathology and Forensic Medicine 1.7k
- Oncology 1.7k
- Genetics 566
- Hematology 517
- Neurology 434
Countries citing papers authored by Catherine Spier
This map shows the geographic impact of Catherine Spier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Spier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Spier more than expected).
Fields of papers citing papers by Catherine Spier
This network shows the impact of papers produced by Catherine Spier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Spier. The network helps show where Catherine Spier may publish in the future.
Co-authors
The 25 scholars most cited alongside Catherine Spier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 73 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Chemotherapy Alone Compared with Chemotherapy plus Radiotherapy for Localized Intermediate- and High-Grade Non-Hodgkin's Lymphoma Hit paper breakdown → | 1998 | 714 |
| 2 | 1991 | 328 | |
| 3 | 1990 | 260 | |
| 4 | 1993 | 239 | |
| 5 | 2008 | 180 | |
| 6 | 2012 | 122 | |
| 7 | 1991 | 106 | |
| 8 | 2015 | 91 | |
| 9 | 1988 | 82 | |
| 10 | Optimization of immunocytochemical P-glycoprotein assessment in multidrug-resistant plasma cell myeloma using three antibodies. | 1990 | 79 |
| 11 | 2005 | 74 | |
| 12 | 1999 | 73 | |
| 13 | 1987 | 73 | |
| 14 | 2001 | 65 | |
| 15 | 2012 | 62 | |
| 16 | 2018 | 58 | |
| 17 | 1987 | 58 | |
| 18 | 1993 | 54 | |
| 19 | Tumor-infiltrating T-lymphocytes in B-cell diffuse large cell lymphoma related to disease course. | 1990 | 52 |
| 20 | 1990 | 50 |
About Catherine Spier
Catherine Spier is a scholar working on Pathology and Forensic Medicine, Oncology, Genetics, Molecular Biology and Immunology, having authored 73 papers that have together received 3.6k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (44 papers), Chronic Lymphocytic Leukemia Research (17 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), Drug Transport and Resistance Mechanisms (6 papers), Viral-associated cancers and disorders (6 papers), Ubiquitin and proteasome pathways (5 papers), T-cell and Retrovirus Studies (5 papers) and CNS Lymphoma Diagnosis and Treatment (5 papers). The work is most often cited by research in Pathology and Forensic Medicine (1.7k citations), Oncology (1.7k citations), Genetics (566 citations), Hematology (517 citations) and Neurology (434 citations). Catherine Spier has collaborated with scholars based in United States, Netherlands and Malaysia. Frequent co-authors include Thomas M. Grogan, Thomas P. Miller, Richard I. Fisher, Michael LeBlanc, William S. Dalton, TP Miller, Ellen Chase, David J. Adelstein, Steve Dahlberg and J. Robert Cassady. Their work appears in journals such as Blood, Journal of Clinical Oncology, Cancer, Molecular Cancer Therapeutics and Cancer Immunology Immunotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.